BIOMEDCENTRAL . COM {
}
Title[redir]:
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog | BMC Cancer | Peer Review
Description:
The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Polycomb group of proteins plays an important role in the regulation of stem cell self-renewal and is elevated in several cancers. In the current study, we have explored the role of Bmi1 in regulating the stemness and drug resistance of breast cancer cells. Using real time PCR and immunohistochemistry primary breast tissues were analyzed. Retro- and lentiviruses were utilized to overexpress and knockdown Bmi1, RT-PCR and Western blot was performed to evaluate mRNA and protein expression. Stemness properties were analyzed by flow cytometry and sphere-formation and tumor formation was determined by mouse xenograft experiments. Dual luciferase assay was employed to assess promoter activity and MTT assay was used to analyze drug response. We found Bmi1 overexpression in 64% of grade III invasive ductal breast adenocarcinomas compared to normal breast tissues. Bmi1 overexpression in immortalized and transformed breast epithelial cells increased their sphere-forming efficiency, induced epithelial to mesenchymal transition (EMT) with an increase in the expression of stemness-related genes. Knockdown of Bmi1 in tumorigenic breast cells induced epithelial morphology, reduced expression of stemness-related genes, decreased the IC50 values of doxorubicin and abrogated tumor-formation. Bmi1-high tumors showed elevated Nanog expression whereas the tumors with lower Bmi1 showed reduced Nanog levels. Overexpression of Bmi1 increased Nanog levels whereas knockdown of Bmi1 reduced its expression. Dual luciferase promoter-reporter assay revealed Bmi1 positively regulated the Nanog and NFκB promoter activity. RT-PCR analysis showed that Bmi1 overexpression activated the NFκB pathway whereas Bmi1 knockdown reduced the expression of NFκB target genes, suggesting that Bmi1 might regulate Nanog expression through the NFκB pathway. Our study showed that Bmi1 is overexpressed in several high-grade, invasive ductal breast adenocarcinomas, thus supporting its role as a prognostic marker. While Bmi1 overexpression increased self-renewal and promoted EMT, its knockdown reversed EMT, reduced stemness, and rendered cells drug sensitive, thus highlighting a crucial role for Bmi1 in regulating the stemness and drug response of breast cancer cells. Bmi1 may control self-renewal through the regulation of Nanog expression via the NFκB pathway.
Matching Content Categories {📚}
- Education
- Social Networks
- Science
Content Management System {📝}
What CMS is biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of biomedcentral.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,620,129 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Biomedcentral.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Biomedcentral.com Make? {💰}
Display Ads {🎯}
$70,900 per month
Our analysis indicates Biomedcentral.com generates between $47,251 and $129,940 monthly online from display ads.
Keywords {🔍}
version, bmc, author, manuscript, reviewed, reviewer, report, cookies, submitted, privacy, resubmission, responded, comments, annapoorni, rangarajan, raj, puri, jul, page, data, information, cancer, submission, jan, sep, article, optional, content, personal, parties, policy, manage, published, peer, review, original, yeon, sun, seong, jun, oct, contact, enquiries, editing, authors, choice, essential, make, site, function,
Topics {✒️}
authors scientific editing privacy choices/manage cookies breast cancer cells bmc european economic area state privacy rights accepting optional cookies peer review 1471-2407 contact manage preferences article published author responded personal data submission enquiries optional cookies data protection essential cookies cookies skip cookies policy privacy policy privacy statement usage analysis social media varying standards bmi1 regulates mesenchymal transition editorially accepted general enquiries preference centre springer nature content choices 28 oct 2014 privacy puri 18 published choice make site function advertising personalisation consent processing parties information change accept renewal epithelial
Schema {🗺️}
WebPage:
mainEntity:
headline:Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
description:The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Polycomb group of proteins plays an important role in the regulation of stem cell self-renewal and is elevated in several cancers. In the current study, we have explored the role of Bmi1 in regulating the stemness and drug resistance of breast cancer cells. Using real time PCR and immunohistochemistry primary breast tissues were analyzed. Retro- and lentiviruses were utilized to overexpress and knockdown Bmi1, RT-PCR and Western blot was performed to evaluate mRNA and protein expression. Stemness properties were analyzed by flow cytometry and sphere-formation and tumor formation was determined by mouse xenograft experiments. Dual luciferase assay was employed to assess promoter activity and MTT assay was used to analyze drug response. We found Bmi1 overexpression in 64% of grade III invasive ductal breast adenocarcinomas compared to normal breast tissues. Bmi1 overexpression in immortalized and transformed breast epithelial cells increased their sphere-forming efficiency, induced epithelial to mesenchymal transition (EMT) with an increase in the expression of stemness-related genes. Knockdown of Bmi1 in tumorigenic breast cells induced epithelial morphology, reduced expression of stemness-related genes, decreased the IC50 values of doxorubicin and abrogated tumor-formation. Bmi1-high tumors showed elevated Nanog expression whereas the tumors with lower Bmi1 showed reduced Nanog levels. Overexpression of Bmi1 increased Nanog levels whereas knockdown of Bmi1 reduced its expression. Dual luciferase promoter-reporter assay revealed Bmi1 positively regulated the Nanog and NFκB promoter activity. RT-PCR analysis showed that Bmi1 overexpression activated the NFκB pathway whereas Bmi1 knockdown reduced the expression of NFκB target genes, suggesting that Bmi1 might regulate Nanog expression through the NFκB pathway. Our study showed that Bmi1 is overexpressed in several high-grade, invasive ductal breast adenocarcinomas, thus supporting its role as a prognostic marker. While Bmi1 overexpression increased self-renewal and promoted EMT, its knockdown reversed EMT, reduced stemness, and rendered cells drug sensitive, thus highlighting a crucial role for Bmi1 in regulating the stemness and drug response of breast cancer cells. Bmi1 may control self-renewal through the regulation of Nanog expression via the NFκB pathway.
datePublished:2014-10-28T00:00:00Z
dateModified:2014-10-28T00:00:00Z
pageStart:1
pageEnd:14
license:https://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/1471-2407-14-785
keywords:
Bmi1
Breast cancer stem cells
Drug-resistance
Epithelial to mesenchymal transition
Nanog
NFκB
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig5_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:14
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Anurag N Paranjape
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Sai A Balaji
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Tamoghna Mandal
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Esthelin Vittal Krushik
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Pradeep Nagaraj
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Geetashree Mukherjee
affiliation:
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Annapoorni Rangarajan
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
description:The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Polycomb group of proteins plays an important role in the regulation of stem cell self-renewal and is elevated in several cancers. In the current study, we have explored the role of Bmi1 in regulating the stemness and drug resistance of breast cancer cells. Using real time PCR and immunohistochemistry primary breast tissues were analyzed. Retro- and lentiviruses were utilized to overexpress and knockdown Bmi1, RT-PCR and Western blot was performed to evaluate mRNA and protein expression. Stemness properties were analyzed by flow cytometry and sphere-formation and tumor formation was determined by mouse xenograft experiments. Dual luciferase assay was employed to assess promoter activity and MTT assay was used to analyze drug response. We found Bmi1 overexpression in 64% of grade III invasive ductal breast adenocarcinomas compared to normal breast tissues. Bmi1 overexpression in immortalized and transformed breast epithelial cells increased their sphere-forming efficiency, induced epithelial to mesenchymal transition (EMT) with an increase in the expression of stemness-related genes. Knockdown of Bmi1 in tumorigenic breast cells induced epithelial morphology, reduced expression of stemness-related genes, decreased the IC50 values of doxorubicin and abrogated tumor-formation. Bmi1-high tumors showed elevated Nanog expression whereas the tumors with lower Bmi1 showed reduced Nanog levels. Overexpression of Bmi1 increased Nanog levels whereas knockdown of Bmi1 reduced its expression. Dual luciferase promoter-reporter assay revealed Bmi1 positively regulated the Nanog and NFκB promoter activity. RT-PCR analysis showed that Bmi1 overexpression activated the NFκB pathway whereas Bmi1 knockdown reduced the expression of NFκB target genes, suggesting that Bmi1 might regulate Nanog expression through the NFκB pathway. Our study showed that Bmi1 is overexpressed in several high-grade, invasive ductal breast adenocarcinomas, thus supporting its role as a prognostic marker. While Bmi1 overexpression increased self-renewal and promoted EMT, its knockdown reversed EMT, reduced stemness, and rendered cells drug sensitive, thus highlighting a crucial role for Bmi1 in regulating the stemness and drug response of breast cancer cells. Bmi1 may control self-renewal through the regulation of Nanog expression via the NFκB pathway.
datePublished:2014-10-28T00:00:00Z
dateModified:2014-10-28T00:00:00Z
pageStart:1
pageEnd:14
license:https://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/1471-2407-14-785
keywords:
Bmi1
Breast cancer stem cells
Drug-resistance
Epithelial to mesenchymal transition
Nanog
NFκB
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-14-785/MediaObjects/12885_2014_Article_4966_Fig5_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:14
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Anurag N Paranjape
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Sai A Balaji
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Tamoghna Mandal
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Esthelin Vittal Krushik
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Pradeep Nagaraj
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Geetashree Mukherjee
affiliation:
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
type:Organization
type:Person
name:Annapoorni Rangarajan
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Cancer
issn:
1471-2407
volumeNumber:14
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Anurag N Paranjape
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
type:Organization
name:Sai A Balaji
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Tamoghna Mandal
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Esthelin Vittal Krushik
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Pradeep Nagaraj
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
name:Geetashree Mukherjee
affiliation:
name:Kidwai Memorial Institute of Oncology
address:
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
type:PostalAddress
type:Organization
name:Annapoorni Rangarajan
affiliation:
name:Indian Institute of Science
address:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
name:Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
name:Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
External Links {🔗}(17)
- What's the financial gain of https://submission.nature.com/new-submission/12885/3?
- What's the total monthly financial gain of https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_AuthorComment_V2.pdf?
- How much money does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V2_R1.pdf generate?
- Get to know https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V2_R2.pdf's earnings
- What is the earnings of https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V2_R3.pdf?
- How much does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_AuthorComment_V3.pdf generate monthly?
- Discover the revenue of https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V3_R1.pdf
- How much revenue does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V3_R2.pdf produce monthly?
- Learn about the earnings of https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_AuthorComment_V4.pdf
- How much profit does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V4_R1.pdf generate?
- How much does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_AuthorComment_V5.pdf bring in each month?
- How much cash flow does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-14-785/12885_2014_4966_ReviewerReport_V5_R1.pdf have monthly?
- What is the monthly revenue of https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022?
- How much does https://biomedcentral.typeform.com/to/VLXboo make?
- Financial intake of http://www.weibo.com/biomedcentral
- How much does https://www.springernature.com/ccpa make?
- How much money does https://www.springernature.com generate?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref